327 related articles for article (PubMed ID: 19245933)
1. Thrombocytopenia in myelodysplastic syndromes and myelofibrosis.
Boruchov AM
Semin Hematol; 2009 Jan; 46(1 Suppl 2):S37-43. PubMed ID: 19245933
[TBL] [Abstract][Full Text] [Related]
2. Platelet counts and haemorrhagic diathesis in patients with myelodysplastic syndromes.
Neukirchen J; Blum S; Kuendgen A; Strupp C; Aivado M; Haas R; Aul C; Gattermann N; Germing U
Eur J Haematol; 2009 Nov; 83(5):477-82. PubMed ID: 19548919
[TBL] [Abstract][Full Text] [Related]
3. Involvement of transforming growth factor-beta and thrombopoietin in the pathogenesis of myelodysplastic syndrome with myelofibrosis.
Akiyama T; Matsunaga T; Terui T; Miyanishi K; Tanaka I; Sato T; Kuroda H; Takimoto R; Takayama T; Kato J; Yamauchi N; Kogawa K; Sakamaki S; Hirayama Y; Kohda K; Niitsu Y
Leukemia; 2005 Sep; 19(9):1558-66. PubMed ID: 16034467
[TBL] [Abstract][Full Text] [Related]
4. Myelodysplasic syndromes: a comprehensive review.
Catenacci DV; Schiller GJ
Blood Rev; 2005 Nov; 19(6):301-19. PubMed ID: 15885860
[TBL] [Abstract][Full Text] [Related]
5. Supportive care including growth factors in myelodysplastic syndromes.
Gardin C; Fenaux P
Rev Clin Exp Hematol; 2004 Dec; 8(2):E3. PubMed ID: 16027101
[TBL] [Abstract][Full Text] [Related]
6. Hematopoietic growth factors in the treatment of acquired bone marrow failure states.
Marsh JC; Ganser A; Stadler M
Semin Hematol; 2007 Jul; 44(3):138-47. PubMed ID: 17631178
[TBL] [Abstract][Full Text] [Related]
7. Inherited thrombocytopenia and platelet disorders with germline predisposition to myeloid neoplasia.
Galera P; Dulau-Florea A; Calvo KR
Int J Lab Hematol; 2019 May; 41 Suppl 1():131-141. PubMed ID: 31069978
[TBL] [Abstract][Full Text] [Related]
8. Supportive care and use of hematopoietic growth factors in myelodysplastic syndromes.
Hellström-Lindberg E; Malcovati L
Semin Hematol; 2008 Jan; 45(1):14-22. PubMed ID: 18179965
[TBL] [Abstract][Full Text] [Related]
9. Myelodysplasia: when to treat and how.
Larson RA
Best Pract Res Clin Haematol; 2006; 19(2):293-300. PubMed ID: 16516126
[TBL] [Abstract][Full Text] [Related]
10. Tolerability, pharmacodynamics, and pharmacokinetics studies of depsipeptide (romidepsin) in patients with acute myelogenous leukemia or advanced myelodysplastic syndromes.
Klimek VM; Fircanis S; Maslak P; Guernah I; Baum M; Wu N; Panageas K; Wright JJ; Pandolfi PP; Nimer SD
Clin Cancer Res; 2008 Feb; 14(3):826-32. PubMed ID: 18245545
[TBL] [Abstract][Full Text] [Related]
11. Reticulated platelet counts correlate with treatment response in patients with idiopathic thrombocytopenic purpura and help identify the complex causes of thrombocytopenia in patients after allogeneic hematopoietic stem cell transplantation.
Thomas-Kaskel AK; Mattern D; Köhler G; Finke J; Behringer D
Cytometry B Clin Cytom; 2007 Jul; 72(4):241-8. PubMed ID: 17266149
[TBL] [Abstract][Full Text] [Related]
12. Danazol for the treatment of thrombocytopenia in patients with myelodysplastic syndrome.
Chan G; DiVenuti G; Miller K
Am J Hematol; 2002 Nov; 71(3):166-71. PubMed ID: 12410570
[TBL] [Abstract][Full Text] [Related]
13. [Results of selected cytochemical studies of mature granulocytes in myelodysplastic syndromes and various other hematologic diseases].
Mariańska B; Apel D; Maj S
Acta Haematol Pol; 1991; 22(1):54-7. PubMed ID: 1823968
[TBL] [Abstract][Full Text] [Related]
14. The myelodysplastic syndromes and myeloproliferative disorders.
Williams JL
Clin Lab Sci; 2004; 17(4):223-34. PubMed ID: 15559729
[TBL] [Abstract][Full Text] [Related]
15. Thrombocythaemic erythromelalgia in chronic myeloproliferative and myelodysplastic disorders.
Michiels JJ; Hagemeyer A; Prins ME
Neth J Med; 1989 Aug; 35(1-2):4-10. PubMed ID: 2779694
[TBL] [Abstract][Full Text] [Related]
16. Myelodysplastic syndromes (MDS) and acute myeloid leukemias (AML) with myelofibrosis.
Imbert M; Nguyen D; Sultan C
Leuk Res; 1992; 16(1):51-4. PubMed ID: 1732672
[TBL] [Abstract][Full Text] [Related]
17. Bernard-Soulier-like functional platelet defect in myelodysplastic syndrome and in acute myeloblastic leukemia associated with trilineage myelodysplasia.
Hiçsönmez G; Gümrük F; Cetin M; Ozbek N; Tuncer M; Gürsel T
Turk J Pediatr; 1995; 37(4):425-9. PubMed ID: 8560614
[TBL] [Abstract][Full Text] [Related]
18. Thrombopoietic factors in chronic bone marrow failure states: the platelet problem revisited.
Kurzrock R
Clin Cancer Res; 2005 Feb; 11(4):1361-7. PubMed ID: 15746033
[TBL] [Abstract][Full Text] [Related]
19. Clinical spectrum, outcome and management of immune thrombocytopenia associated with myelodysplastic syndromes and chronic myelomonocytic leukemia.
Jachiet V; Moulis G; Hadjadj J; Seguier J; Laribi K; Schleinitz N; Vey N; Sacre K; Godeau B; Beyne-Rauzy O; Bouvet R; Broner J; Brun N; Comont T; Gaudin C; Lambotte O; Le Clech L; Peterlin P; Roy-Peaud F; Salvado C; Versini M; Isnard F; Kahn JE; Gobert D; Adès L; Fenaux P; Fain O; Mekinian A
Haematologica; 2021 May; 106(5):1414-1422. PubMed ID: 33626866
[TBL] [Abstract][Full Text] [Related]
20. Thrombopoiesis-stimulating agents and myelodysplastic syndromes.
Brierley CK; Steensma DP
Br J Haematol; 2015 May; 169(3):309-23. PubMed ID: 25659186
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]